High-fidelity virus stocks and derivative products available at any volume, with pricing at or below in-house cost of production. Shop online or speak with a representative to place a custom order.
Ensure precision and reliability in your research and manufacturing with our high-fidelity solutions—shop our virus stocks and derivative products online or speak with a representative to place a custom order.
Pharma and biotech leaders trust our expertise in virus production and quality control, backed by our industry leading processes. We ensure the highest standards in virus production and quality control, delivering high-fidelity virus stocks and derivative products for consistent results. Our commitment to regulatory excellence guarantees full compliance with industry standards and industry leading transparency. With accelerated timelines, we provide scalable solutions to meet critical deadlines.
Pharma and biotech leaders trust our expertise in virus production and quality control, backed by our industry leading processes. We ensure the highest standards in virus production and quality control, delivering high-fidelity virus stocks and derivative products for consistent results. Our commitment to regulatory excellence guarantees full compliance with industry standards and industry leading transparency. With accelerated timelines, we provide scalable solutions to meet critical deadlines.
We provide the exact volume of virus stock or derivative product your study requires, from small seed stocks to large-scale batches. We deliver experiment-ready quantities at a price equivalent to or lower than your in-house production costs.
Join us at the Palais des congrès de Montréal as we connect with leading virologists and biotech innovators. Our team will be available throughout the conference to discuss our reverse genetics based scalable virus production platform, and custom preclinical and clinical research solutions.
Discover how our high-fidelity virus stocks and custom-engineered viral tools are driving progress in:
Interested in a one-on-one meeting at the event?
Parts 1 and 2 of this series covered a small BSL-2 project and a mid-size BSL-3 project, where buying won by wide margins. This post looks at the scenario where...
In Part 1 of this series, we broke down the math for a small BSL-2 project — an influenza plaque assay validation, where buying won by more than 20x. This...
This is the first in a three-part series putting real numbers behind the make-versus-buy question for experiment-ready virus. Each post walks through one representative project — how much virus it...
We develop cutting-edge plasmid-based reverse genetics systems and use them to manufacture high-fidelity virus stocks, reporter viruses, viral genomic material, custom mutants, and other custom virus solutions for vaccine development, antiviral research, diagnostics, and academic research.
Reverse genetics allows us to engineer viruses from genetic sequences using plasmid-based systems, providing precise control over viral characteristics for research applications. We specialize in de novo production of new virus strains and can create any virus needed, including difficult-to-grow strains.
Our clients include biotechnology companies developing vaccines and antivirals, pharmaceutical manufacturers conducting drug discovery, diagnostic companies developing and testing assays, and academic and government research institutions performing basic virology research.
All virus stocks include best-in-class QC standards: titer confirmation, next-generation sequencing verification, sterility testing, and endotoxin analysis. We also provide tailored purification and QC solutions based on specific project needs.
We work with alphaviruses, flaviviruses, coronaviruses, influenza, respiratory syncytial virus, parainfluenza viruses, human metapneumovirus, norovirus, rotavirus, measles virus, and custom viruses. We can also create reporter protein-expressing versions of any strain.
Custom projects typically require multiple weeks depending on complexity and specifications. We offer large-scale production capabilities up to 50L per production run and can provide volume expansion from seed stocks.
Subscribe to our newsletter for industry insights and research updates.
Subscribe to our newsletter for industry
insights and research updates.